Post-marketing Surveillance (PMS) on long term use of Ofev Capsules in Systemic Scleroderma associated Interstitial Lung Disease (SSc-ILD) in Japan (PMS for Ofev (SSc-ILD)) First published 23/12/2019 Last updated 04/12/2025 EU PAS number:EUPAS32905 Study Ongoing